Stay updated on Pembrolizumab in Recurrent Gastric Cancer Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab in Recurrent Gastric Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab in Recurrent Gastric Cancer Clinical Trial page

  1. Check
    3 days ago
    No Change Detected
  2. Check
    11 days ago
    Change Detected
    Summary
    The page now renders a 403 Forbidden error instead of the study record. This makes the study details and navigation inaccessible to users.
    Difference
    21%
    Check dated 2026-09-20T04:51:46.000Z thumbnail image
  3. Check
    18 days ago
    No Change Detected
  4. Check
    32 days ago
    Change Detected
    Summary
    The study record adds a U.S. NIH grant/contract funding line, and the page footer updates to Revision: v3.6.6, indicating a minor version update.
    Difference
    0.1%
    Check dated 2026-08-29T23:43:08.000Z thumbnail image
  5. Check
    53 days ago
    Change Detected
    Summary
    The page’s revision is updated to v3.6.5 from v3.6.4, indicating a minor internal update to the page.
    Difference
    0.0%
    Check dated 2026-08-08T20:00:24.000Z thumbnail image
  6. Check
    67 days ago
    Change Detected
    Summary
    The page revision was updated from v3.6.3 to v3.6.4, indicating a new deployment of the site. This update does not reflect a substantive change to the study details or content on the page.
    Difference
    0.0%
    Check dated 2026-07-25T12:32:28.000Z thumbnail image
  7. Check
    89 days ago
    Change Detected
    Summary
    The page's revision tag was updated from v3.6.2 to v3.6.3. This indicates a new release of the page content.
    Difference
    0.0%
    Check dated 2026-07-03T23:53:15.000Z thumbnail image
  8. Check
    96 days ago
    Change Detected
    Summary
    The page's revision label updated from v3.6.0 to v3.6.2, indicating a newer version of the page template. This update does not alter any study content, eligibility criteria, or results.
    Difference
    0.0%
    Check dated 2026-06-26T19:46:42.000Z thumbnail image

Stay in the know with updates to Pembrolizumab in Recurrent Gastric Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab in Recurrent Gastric Cancer Clinical Trial page.